Merck Expands BioReliance® Viral Clearance Offering in Singapore, Saving Customers Time
Allows customers to continue developing lifesaving medicines amid Covid-19 pandemic Customers can view the lab studies “live” with Merck scientists SINGAPORE – Media OutReach – 15 September 2020 – Merck, a leading science and technology company, today announced an expansion of its Singapore biosafety testing laboratory services. These services allow customers to conduct viral clearance studies that ensure the safety and quality of their biological drugs during the clinical development process. […]